AI healthcare tech startup Signos expands partnership with Dexcom
Signs combines a wearable glucose monitor with an app powered by artificial intelligence. Source: Signs Health technology startup Signos announced…
Eli Lilly and company
Eli Lilly's weight-loss drug retatrutide passes obesity trial
Eli Lilly on Thursday said its next-generation drug passed a crucial late-stage trial in obese patients, achieving significant weight loss…
Eli Lilly Lawsuit Says Refund Fraud Linked to Pentecostal Church Leaders
Eli Lilly says it has uncovered a long-running scheme to steal more than $200 million in rebates for its diabetes…
White House Adds Generic Drugs to TrumpRx Direct-to-Consumer Site
President Donald Trump speaks to introduce the TrumpRx website in the South Court Auditorium of the White House in Washington,…
Bristol Myers Squibb turns to China's Hengrui to replace pipeline
One of the largest U.S. pharmaceutical companies said this week that it will partner with a Chinese drugmaker to test…
Biogen drug against Alzheimer's enters advanced phase of trial
A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters biogen plans to advance an experimental Alzheimer's disease drug into…
Novo Nordisk releases new Wegovy data on high doses
A Wegovy injection pen is shown in Waterbury, Vermont, on April 28, 2025. Shelby Knowles | Bloomberg | fake images…
Novo Nordisk CEO Mike Doustdar says Ozempic maker looking for deals
Nordisk is looking for deals more than ever, the Danish drugmaker's CEO said Wednesday in an interview with CNBC. “If…
Eli Lilly (LLY) earnings in the first quarter of 2026
Eli Lilly on Thursday reported first-quarter earnings and revenue that beat estimates and raised its full-year sales outlook by $2…
Eli Lilly Stock Rising Rapidly, Proving Stock Plunge Was a Mistake
Obesity drug giant Eli Lilly reported a monster first quarter on Thursday, strengthening our conviction to hold the stock after…